Janux Therapeutics, Inc.
USD15.37
+0.04 (+0.29%)
CEO
David Alan Campbell
IPO Date
2021-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.02
Prev. Close
$15.32
Day Low
$15.02
Day High
$15.44
52W Low
$12.12
52W High
$35.34
Market Cap
$0.94B
Volume
0.02M
| 15,500 |
| $13.66 |
| 12 Jun 2026 | Simson Jake | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Simson Jake | director | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | Kung Winston | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Kung Winston | director | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | Hernday Natasha | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | Hernday Natasha | director | A-Award | Acquired | 15,500 | $13.66 |
| 12 Jun 2026 | DOBMEIER ERIC | director | A-Award | Acquired | 5,500 | $0.00 |
| 12 Jun 2026 | DOBMEIER ERIC | director | A-Award | Acquired | 15,500 | $13.66 |